Cardiff Oncology: Data Update Resolves Some Signals

Cardiff Oncology (NASDAQ: CRDF ) is a company I've been following for quite some time now, and back in May , I prepared an article going over an anticipated data readout. This upcoming presentation ofI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing in ...